Related Experiment Video
Updated: Feb 22, 2026
Three Different Protocols of Corneal Collagen Crosslinking in Keratoconus: Conventional, Accelerated and Iontophoresis
Published on: November 12, 2015
Recent advances in corneal collagen cross-linking.
Gitansha Shreyas Sachdev1, Mahipal Sachdev2
1Dr. Gitansha Shreyas Sachdev, The Eye Foundation, Coimbatore, India.
Corneal collagen cross-linking (CXL) is a leading treatment for corneal ectasia. Advancements in CXL technology offer customized treatments for improved efficacy and potential refractive correction.
Area of Science:
- Ophthalmology
- Biomedical Engineering
Background:
- Corneal collagen cross-linking (CXL) is the standard treatment for corneal ectasia.
- Conventional CXL protocols are well-established for safety and efficacy.
Purpose of the Study:
- To review advancements in corneal collagen cross-linking technology.
- To highlight evolving clinical applications of CXL.
Main Methods:
- Review of current literature on CXL advancements.
- Analysis of new riboflavin formulations and irradiation patterns.
- Exploration of accelerated and pulsed CXL protocols.
Main Results:
- Evolving CXL protocols include accelerated, pulsed, and customized irradiation.
- Newer riboflavin formulations enhance treatment delivery.
- CXL shows potential for refractive correction and preventing post-LASIK regression.
Conclusions:
- Customized CXL approaches are the future, aiming for refractive improvement and disease stability.
- Further research into CXL for myopic correction and combination therapies is ongoing.
More Related Videos
12:25Second Harmonic Generation Signals in Rabbit Sclera As a Tool for Evaluation of Therapeutic Tissue Cross-linking TXL for Myopia
Published on: January 6, 2018
05:56Scleral Cross-linking Using Riboflavin and Ultraviolet-A Radiation for Prevention of Axial Myopia in a Rabbit Model
Published on: April 3, 2016
